Results 111 to 120 of about 29,109,104 (283)

Analogical asides on case-based reasoning [PDF]

open access: yes, 1994
This paper explores some of the similarities and differences between cognitive models of analogy and case-based reasoning systems. I first point out a paradox in the treatment of adaptation in analogy and in case-based reasoning; a paradox which can be only resolved by expanding the role of adaptation in cognitive models of analogy.
openaire   +2 more sources

Membrane composition and thermodynamic identity as boundaries of life for synthetic cell research

open access: yesFEBS Letters, EarlyView.
What makes a cell a cell? The boundary of a living cell is not just a wall. Read as a Markov blanket, the membrane separates internal from external states, generating identity and non‐equilibrium order. Can this identity be rebuilt from scratch in a synthetic cell?
Caterina Presutti, Bert Poolman
wiley   +1 more source

A Case with a View - Towards an Integration of Visual and Case-Based Reasoning in Design

open access: yes, 2001
Despite the long-term effort to establish the theoretical foundations for Case-Based Reasoning (CBR) in design, it appears that additional theoretical efforts are needed in order to achieve the promise of this affinity. In this paper we argue that visual
R. Oxman, A. Heylighen
core  

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

open access: yesMolecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge   +17 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Applying the Case-Based Axiomatic Design Assistant (CADA) to a Pharmaceutical Engineering Task: Implementation and Assessment

open access: yesComputers
Modern custom machine construction and automation projects face pressure to shorten innovation cycles, reduce durations, and manage growing system complexity.
Roland Wölfle   +2 more
doaj   +1 more source

Stimulator of interferon genes agonist augmented antitumor immunity of osimertinib in Egfr‐mutated lung cancer

open access: yesMolecular Oncology, EarlyView.
Combining osimertinib with the STING agonist ADU‐S100 activates innate and adaptive immunity to overcome the non‐inflamed microenvironment of Egfr‐mutant lung cancer. This combination increases NK and CD8+ T‐cell infiltration, associated with activation of the STING‐IRF3 pathway and local immunogenic cell death.
Jun Nishimura   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy